neurodegenerative disease | GenomeWeb

neurodegenerative disease

ImmunArray will use Quanterix's Simoa single-molecule array technology for biomarker analysis, with the potential to enrich its diagnostic panels.

The funding will support development of tests that detect cell-free DNA methylation patterns indicative of disease in specific tissues of the body.

The RNA products developer is buying California-based Narus in order to expand into the RNA-based diagnostics market.

The companies will evaluate Diamir's technology as a potential companion diagnostic to certain Janssen neurodegenerative disease programs.

UK-based XRGenomics is using Affymetrix's GeneTitan platform to develop a gene expression signature as a stratification tool for dementia research.

The San Francisco-based startup looks to apply its algorithms to gene networks implicated in neurodegenerative diseases to find drug targets.

The test is based on a technology developed by an Amprion co-founder for the amplification of prions.

DioGenix and its MSPrecise NGS test for multiple sclerosis will be merged into Amarantus as a foundational asset of a growing neuro-diagnostic business.

NEW YORK (GenomeWeb) – Japanese stem cell products company Reprocell said today that it has purchased 3D cell culture firm Reinnervate and US genomics services firm BioServe.

NEW YORK (GenomeWeb) – The Quebec Consortium for Drug Discovery (CQDM) and the nonprofit Brain Canada plan to provide at least C$10 million (US$9.2 million) for researchers developing tools, technologies, and platforms that will speed drug development for brain and nervous system disorders.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.